Abeona Therapeutics
ABEO
ABEO
58 hedge funds and large institutions have $71.6M invested in Abeona Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 1.49% → 1.43% (-0.05%)
1% less capital invested
Capital invested by funds: $72M → $71.6M (-$459K)
Holders
58
Holding in Top 10
1
Calls
$132K
Puts
$103K
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.42M | |
| 3 | +$1.29M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$649K |
| 5 |
Goldman Sachs
New York
|
+$520K |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$1.1M | |
| 3 | -$686K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$625K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$500K |